IDEAYA Biosciences Inc (NAS:IDYA)
$ 26.66 -0.79 (-2.88%) Market Cap: 2.30 Bil Enterprise Value: 1.47 Bil PE Ratio: 0 PB Ratio: 1.95 GF Score: 30/100

IDEAYA Biosciences Inc at Goldman Sachs Healthcare Conference Transcript

Jun 15, 2023 / 05:40PM GMT
Release Date Price: $24.94 (+0.40%)
Unidentified Analyst

For our last session of the day, thanks so much to the team from IDEAYA Biosciences for joining us. Maybe just quickly an introduction from both of you. And if you could, a brief overview (technical difficulty) today and with respect to what your value drivers are.

Yujiro Hata
IDEAYA Biosciences, Inc. - President & CEO

Sure. Well, first, thank you so much, Karen, for the kind invitation to participate this year. Yujiro Hata, President and CEO. I can maybe let Darrin do a quick introduction as well, and I'm happy to go through a quick overview.

Darrin Beaupre
IDEAYA Biosciences, Inc. - Chief Medical Officer

Yeah. Hi, I am Darrin Beaupre. I'm the Chief Medical Officer at IDEAYA Biosciences. I've been with the company for about seven or eight months now. My background is I'm a medical oncologist, hematologist, PhD in cancer biology. Started out at the Moffitt Cancer Center, but I've been in the industry 16 years. Joined IDEAYA because of an amazing pipeline that you're going to hear about.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot